Showing results (821-830 of 1,602) with videos related to

Sort By:
Pageof 161
RSC Medicinal Chemistry|May 27, 2024
SETDB1 as a cancer target: challenges and perspectives in drug designHaifa Hassanie, André Berndt Penteado, Larissa Costa de Almeida, et al.
RSC Medicinal Chemistry|June 1, 2022
Synthesis of potent antifungal 3,4-dichloroisothiazole-based strobilurins with both direct fungicidal activity and systemic acquired resistanceDongyan Yang, Xin Qi, Xinhua Zhou, et al.
RSC Medicinal Chemistry|June 1, 2022
Prodrugs of pyrophosphates and bisphosphonates: disguising phosphorus oxyanionsEmma S Rudge, Alex H Y Chan, Finian J Leeper
RSC Medicinal Chemistry|June 1, 2022
RpoN-Based stapled peptides with improved DNA binding suppress Pseudomonas aeruginosa virulenceAndré R Paquette, Sterling R Payne, Geoffrey A McKay, et al.
RSC Medicinal Chemistry|June 13, 2022
Synthesis and evaluation of triazole congeners of nitro-benzothiazinones potentially active against drug resistant Mycobacterium tuberculosis demonstrating bactericidal efficacySantosh Kumar Sahoo, Mohammad Naiyaz Ahmad, Grace Kaul, et al.
RSC Medicinal Chemistry|June 13, 2022
Covalent cannabinoid receptor ligands - structural insight and selectivity challengesIan Liddle, Michelle Glass, Joel D A Tyndall, et al.
RSC Medicinal Chemistry|June 13, 2022
Design, synthesis, and biological evaluation of new thalidomide-donepezil hybrids as neuroprotective agents targeting cholinesterases and neuroinflammationCindy Juliet Cristancho Ortiz, Matheus de Freitas Silva, Letizia Pruccoli, et al.
RSC Medicinal Chemistry|June 13, 2022
Morpholine substituted quinazoline derivatives as anticancer agents against MCF-7, A549 and SHSY-5Y cancer cell lines and mechanistic studiesAshish Ranjan Dwivedi, Vijay Kumar, Vikash Prashar, et al.
RSC Medicinal Chemistry|June 13, 2022
Stereoisomeric Pam2CS based TLR2 agonists: synthesis, structural modelling and activity as vaccine adjuvantsArshpreet Kaur, Sakshi Piplani, Deepender Kaushik, et al.
RSC Medicinal Chemistry|May 28, 2021
Structure-activity relationship studies on 2,5,6-trisubstituted benzimidazoles targeting Mtb-FtsZ as antitubercular agentsKrupanandan Haranahalli, Simon Tong, Saerom Kim, et al.
Pageof 161